Portal:CPTAC
From WikiPathways
(typo) |
(Adding hallmark display) |
||
| Line 24: | Line 24: | ||
{{{{FULLPAGENAME}}/box-normal | {{{{FULLPAGENAME}}/box-normal | ||
|<!-- TITLE OF BOX --> | |<!-- TITLE OF BOX --> | ||
| - | <big>'' | + | <big>''Cancer Hallmark Categories''</big> |
|<!-- EDIT LINK --> | |<!-- EDIT LINK --> | ||
| - | {{FULLPAGENAME}}/ | + | {{FULLPAGENAME}}/Hallmarks |
|<!-- CONTENT LINK --> | |<!-- CONTENT LINK --> | ||
| - | {{FULLPAGENAME}}/ | + | {{FULLPAGENAME}}/Hallmarks |
| | | | ||
}} | }} | ||
| Line 47: | Line 47: | ||
| + | {{{{FULLPAGENAME}}/box-normal | ||
| + | |<!-- TITLE OF BOX --> | ||
| + | <big>''Useful Links''</big> | ||
| + | |<!-- EDIT LINK --> | ||
| + | {{FULLPAGENAME}}/Other | ||
| + | |<!-- CONTENT LINK --> | ||
| + | {{FULLPAGENAME}}/Other | ||
| + | | | ||
| + | }} | ||
</div> | </div> | ||
Revision as of 17:33, 3 October 2017
CPTAC Pathways
Welcome to the CPTAC Pathway PortalThis portal highlights pathway content relevant to the Clinical Proteomic Tumor Analysis Consortium (CPTAC). The National Cancer Institute, part of the National Institutes of Health, announced the launch of a Clinical Proteomic Tumor Analysis Consortium in August 2011. CPTAC is a comprehensive and coordinated effort to accelerate the understanding of the molecular basis of cancer through the application of robust, quantitative, proteomic technologies and workflows. The overarching goal of CPTAC is to improve our ability to diagnose, treat and prevent cancer. To achieve this goal in a scientifically rigorous manner, the NCI launched CPTAC to systematically identify proteins that derive from alterations in cancer genomes and related biological processes, and provide this data with accompanying assays and protocols to the public. The pathways included in this portal have been organized into classic cancer hallmark categories, based on the different biological capabilities acquired during the multistep development of human tumors. To read more, see Hallmarks of cancer: the next generation, Hanahan and Weinberg, Cell 2011. | 
|
Pathway Curation
On this page you see rotating displays of hallmark and featured pathways. Where did these pathways come from? They came from people like you! The CPTAC set of pathways can be edited, fixed and added to using the pathway drawing and annotation tools here at WikiPathways.
Getting Started
- Introduction to WikiPathways (slides)
- WikiPathways Overview or New Contributor Quickstart
- General help pages
- CPTAC Workshop Exercises
Resources
- Learn more about CPTAC
- Pathway analysis
- Cytoscape and the WikiPathways app
- PathVisio and the WikiPathways plugin
Curation projects
- Curating Hallmark Pathways -- How to
- Example: construction of Pathways in Renal Cancer
- Contact Alex Pico if interested in curating, adding or using CPTAC pathways, apico@gladstone.ucsf.edu
Cancer Hallmark Categories
| Sustaining proliferative signaling
FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma (Homo sapiens) Image does not exist FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma | Evading growth suppressors
Cell cycle (Homo sapiens) Image does not exist Cell cycle | Activating invasion and metastasis
Integrin-mediated cell adhesion (Homo sapiens) Image does not exist Integrin-mediated cell adhesion |
| Enabling replicative immortality
Wnt/beta-catenin signaling in leukemia (Homo sapiens) Image does not exist Wnt/beta-catenin signaling in leukemia | Inducing angiogenesis
MSMP expression regulation in cancer cells and its pro-angiogenic role in ovarian tumors (Homo sapiens) Image does not exist MSMP expression regulation in cancer cells and its pro-angiogenic role in ovarian tumors | Resisting cell death
PI3K-AKT-mTOR signaling and therapeutic opportunities in prostate cancer (Homo sapiens) Image does not exist PI3K-AKT-mTOR signaling and therapeutic opportunities in prostate cancer |
| Deregulating cellular energetics
Hereditary leiomyomatosis and renal cell carcinoma pathway (Homo sapiens) Image does not exist Hereditary leiomyomatosis and renal cell carcinoma pathway | Genome instability and mutation
One-carbon metabolism (Homo sapiens) Image does not exist One-carbon metabolism | Tumor promoting inflammation
IL1 signaling (Homo sapiens) Image does not exist IL1 signaling |
| Avoiding immune destruction
Interferon type I signaling (Homo sapiens) Image does not exist Interferon type I signaling | Therapeutics
4-hydroxytamoxifen, dexamethasone, and retinoic acids regulation of p27 expression (Homo sapiens) Image does not exist 4-hydroxytamoxifen, dexamethasone, and retinoic acids regulation of p27 expression |
Featured Pathways
|
Image does not exist PDGFR-beta pathway Zhang, et al. Integrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer |
| View featured pathways |
| List of all pathways for this portal |
